Summary
Since heart rate (HR) is an important determinant of the duration of systole, systolic time intervals (STI) from 8 healthy subjects were examined after infusion of atropine. As no overall correlation was found between HR and pre-ejection period (PEP), the results confirm the need for individual estimates of the correction of the left ventricular ejection time (LVET) and the total electromechanical systole (OS2). In the same subjects the sensitivity of PEP to minor negative inotropic effects of mexiletine and disopyramide measured at Cmax was confirmed. Thus, in addition to its simplicity and reliability, the sensitivity of the uncorrected PEP should encourage use of this technique as part of any screening system for the early detection of an inotropic effect of new chemical entities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almet SS, Levinson GE, Schwarz CJ, Ettinger PO (1972) Systolic time intervals as measures of the contractile state of the left ventricular myocardium in man. Circulation 46: 559–571
Armitage P (1977) Further analysis of straight line data. In: Statistical methods in medical research. Blackwell, Oxford, pp 278–279
Belz GG, Mattews J, Sauer U, Stern H, Schneider B (1984) Pharmacodynamic effects of ouabain following single sublingual. Eur J Clin Pharmacol 26: 287–292
Boudoulas H, Schaa SF, Lewis RP, Welch TG, Degreen P, Kates RE (1977) Negative inotropic effect of lidocaine in patients with coronary arterial disease and normal subjects. Chest 71: 170–174
Cockinos DV, Heimonas ET, Demopoulos JN, Haralambakis A, Tsartsalis G, Gardikas CD (1976) Influence of heart rate increase an uncorrected pre-ejection period/left ventricular ejection time (PEP/LVET) ratio in normal individuals. Br Heart J 38: 683–688
Gibson DG (1980) Use of the systolic time intervals in clinical pharmacology. In: Shanks RG (ed) Cardio-vascular system. 1/Methods in clinical pharmacology, pp 14–19
Harris WS, Schoenfeld CD, Weissler AM (1967) Effects of adrenergic receptor activation and blockade on the systolic pre-ejection period, heart rate and arterial pressure in man. J Clin Invest 46: 1704–1714
Hunt D, Sloman G, Clark RM, Hoffman G (1970) Effects of beta-adrenergic blockade on the systolic time intervals. Am J Med Sci 259: 97–113
Jackson DM (1974) A simple non-invasive technique for measuring cardiac contractility. Lancet 14: 1457
Johnson BF, Meeran MK, Frank A, Taylor SH (1981) Systolic time intervals in measurement of inotropic response to drugs. Br Heart J 46: 513–521
Kelman AW, Sumner DJ, Lawrence JR, Cohiting B (1978) Measurements of systolic time intervals. Br J Clin Pharmacol 6: 549–550
Kelman AW, Sumner DJ, Whiting B (1981) Systolic time intervals versus heart rate regression equations using atropine: Reproductibility studies. Br J Clin Pharmacol 12: 15–20
Kelman AW, Whiting B, Sumner DJ (1984) Correction for equation for ECG time intervals. Br J Clin Pharmacol 18: 113–114
Kyle MC, Freis ED (1980) Serial measurements of systolic time intervals: Effect of propranolol alone and combined with other agents in hypertensive patients. Hypertension 2: 111–117
Levi GF, Ratti S, Cardone G, Basagni M (1982) On the reliability of systolic time intervals. Cardiology 69: 157–165
Rousson D, Piolat C, Galleyrand J, Ferry S, Boissel JP (1986) Systolic time intervals in the evaluation of the negative inotropic effect after single oral dose of mexiletine and disopyramide. Eur J Clin Pharmacol 30: 263–268
Shiner PT, Harris WS, Weissler AM (1969) Effects of acute changes in serum calcium level on the systolic times intervals in man. Am J Cardiol 24: 42–48
Spodick DH, Doi YL, Bishop RL, Hashimoto T (1984) Systolic time intervals reconsidered. Reevaluation of the pre-ejection period: Absence of relation to heart rate. Am J Cardiol 53: 1667–1670
Sullivan TJ, Croft AR, Hanka R, Roberts SJ (1980) Pharmacological screening of new chemical entities in human subjects and methods of data handling. Br J Clin Pharmacol 9: 341–349
Talley RC, Meyer JF, McNay JL (1971) Evaluation of the pre-ejection period as an estimate of myocardial contractility in dogs. Am J Cardiol 27: 384–391
Vanhees L, Fagard R, Grauwels R, Wijnoven J, De Geest H, Amery A (1984) Systolic time intervals in coronary disease at rest and during exercise: effect of physical treaining with and without beta-blockade. Am J Cardiol 54: 508–513
Walsh RA, Crawford MH, O'Rourke RA (1982) Relative sensitivity of echocardiography and systolic time intervals for assessing acute positive inotropic interventions in normal human subjects. Am Heart J 104: 1061–1070
Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37: 149–159
Whiting B, Kelmann AW, Sumner DJ, Hillis WS, Lebermann H (1982) Haemodynamic effects of BM 10-188, a new orally active inotropic agent, in healthy volunteers. Br J Clin Pharmacol 13: 529–532
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rousson, D., Galleyrand, J., Silie, M. et al. Uncorrected pre-ejection period: A simple non-invasive measurement for pharmacodynamic screening of inotropic activity. Eur J Clin Pharmacol 31, 559–562 (1987). https://doi.org/10.1007/BF00606630
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606630